Joao R. Navarro
Research Subjects
Research Interests
Joao R. Navarro has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Harumi Cavarson
AC Camargo Canc Ctr, Inst Int Pesquisa, Sao Paulo, SP, Brazil
1 shared publication - Clovis Antonio Lopes Pinto
AC Camargo Hospital
1 shared publication - Gabriela Venturi
AC Camargo Canc Ctr, Inst Int Pesquisa, Sao Paulo, SP, Brazil
1 shared publication - Glaucia Noeli Maroso Hajj
International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil
1 shared publication - Vladmir Cláudio Cordeiro de Lima
A.C. Camargo Cancer Center, Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 31 December 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (6) , e20210129
Malignant pleural mesothelioma: an update
Malignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces, usually the pleura and peritoneum. They are associated with asbestos exposure, but due to a latency period of more than 30 years and difficult diagnosis, most cases are not detected until they reach advanced stages. Treatment options for this tumor type are very limited and survival ranges from 12 to 36 months. This review discusses the molecular physiopathology, current diagnosis, and latest therapeutic options for this disease.
- 31 December 2021
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 47 (6) , e20210129
Open AccessMalignant pleural mesothelioma: an update
Malignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces, usually the pleura and peritoneum. They are associated with asbestos exposure, but due to a latency period of more than 30 years and difficult diagnosis, most cases are not detected until they reach advanced stages. Treatment options for this tumor type are very limited and survival ranges from 12 to 36 months. This review discusses the molecular physiopathology, current diagnosis, and latest therapeutic options for this disease.